cp wire

CP Wire Articles

HealthCore, Inc., the outcomes research subsidiary of Anthem, Inc. (NYSE: ANTM) and Novo Nordisk Inc., which manufacturers the once weekly GLP-1 receptor agonist Ozempic (semaglutide), are... read more

Wed, 10/17/18 - 10:23 am

Evotec AG (FSE: EVT) (XETRA: EVT) (OTC PINK: EVTCY) and Ferring Pharmaceuticals ("Ferring") today announced a strategic research alliance to discover and develop new small molecule therapies to... read more

Wed, 10/17/18 - 09:44 am

New findings presented on 10/16/18 by CytoReason reveals possible new cellular players in the tumor microenvironment that could impact the treatment process for the most in-need patients –... read more

Tue, 10/16/18 - 09:38 am
  • Non-Alcoholic Fatty Liver Diesease affects over 1 billion people globally
  • TAEUS provides information previously only available via CT and MRI cheaper and at the point of care
  • ... read more
Tue, 10/16/18 - 09:19 am

AmpliPhi Biosciences Corporation (NYSE AMERICAN: APHB) announced on 10/12/18 the pricing of an underwritten public offering of 16,537,500 shares of its common stock (or pre-funded warrants to... read more

Fri, 10/12/18 - 09:36 am

Bristol-Myers Squibb Company (NYSE:BMY) announced on 8/12/18 topline results from the Phase 3 CheckMate -331 study evaluating Opdivo (nivolumab) versus the current standard of care, topotecan or... read more

Fri, 10/12/18 - 09:23 am

Apogenix, a biopharmaceutical company developing next generation immuno-oncology therapeutics, announced today that new data published in Journal of Immunotherapy[1]demonstrate the potent anti-... read more

Thu, 10/11/18 - 10:10 am

Aytu BioScience, Inc. (NASDAQ: AYTU) announced on 10/11/18 the issuance of a U.S. patent covering the company's proprietary MiOXSYS® diagnostic platform for male infertility. This is the first... read more

Thu, 10/11/18 - 09:45 am

Synspira, a privately held company developing a new class of inhaled glycopolymer-based therapeutics for the treatment of pulmonary disease, today announced that it has been granted Orphan... read more

Thu, 10/11/18 - 09:26 am

Tetra Discovery Partners announced on 10/11/18 that the U.S. Patent and Trademark Office has issued a third patent covering the company’s selective phosphodiesterase-4D (PDE4D) inhibitor, BPN... read more

Thu, 10/11/18 - 09:16 am
Data analytics startup Outlier, following its ... read more
Wed, 10/10/18 - 12:01 pm
Delivers industry’s first cross-platform Root Cause Analysis feature and broadens integration support to include Amazon Redshift Spectrum, Apache Druid & Google Ads
... read more
Wed, 10/10/18 - 11:34 am
  • Empagliflozin was estimated to extend life expectancy by 1 to 4.5 years on average
  • In Sept of 2018 it was announced that the class of drugs that includes empagliflozin was associated... read more
Wed, 10/10/18 - 10:08 am
  • Ozanimod had a "beneficial effect" on cognitive processing speed
  • The drug also reduced relapse rates and MRI lesions compared to Avonex
  • Ozanimod is also in development for... read more
Wed, 10/10/18 - 09:50 am

Firalis S.A. (“Firalis”), a Huningue based developer and provider of biomarker products and bioanalytical... read more

Tue, 10/9/18 - 11:44 am

On 10/9/18 FDA Commissioner, Scott Gottlieb MD, announced a series of guidance documents meant to advance the... read more

Tue, 10/9/18 - 10:13 am

Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today announced that it has signed a commercialization plan with Pfizer Inc.  The plan is under an existing... read more

Tue, 10/9/18 - 09:44 am

Rgenix, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule and antibody cancer therapeutics, announced that it has raised $40 million in a Series C financing... read more

Tue, 10/9/18 - 09:23 am
  • So far in September and October of 2018 Altimmune has raised over $60 million
  • On 10/6/18 the company presented data that showed that the company's NasoVAX was well-tolerated and... read more
Mon, 10/8/18 - 10:46 am


current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.